Traditional Chinese medicines (TCM) are a rich source of potential leads for drug development. However, there are fundamental differences between traditional Chinese medical concepts and modern pharmacology, which greatly hinder the modern development of TCM. To address this challenge, new techniques associated with genomics, transcriptomics, proteomics, metabolomics and bioinformatics have been used to dissect the pharmacological mechanisms of TCM. This review article provides an overview of the current research in this area, and illustrates the potential of omic and bioinformatic methods in TCM-based drug discovery.
KaitinK.I. (2010) Deconstructing the drug development process: the new face of innovation. Clinical Pharmacology and Therapeutics, 87, 356–361
2.
RajuT.N. (2000) The Nobel chronicles. Lancet, 355, 1022.
3.
PatersonI., AndersonE.A. (2005) The renaissance of natural products as drug candidates. Science, 310, 451–453.
4.
CorsonT.W., CrewsC.M. (2007) Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell, 130, 769–774.
5.
JiH.F., LiX.J., ZhangH.Y. (2009) Natural products and drug discovery. EMBO Reports, 10, 194–200
6.
Institute of Medicine. (2005) Complementary and Alternative Medicine in the United States.The National Academies Press, New York, USA.
7.
LiX.J., KongD.X., ZhangH.Y. (2010) Chemoinformatics approaches for traditional Chinese medicine research and case application in anticancer drug discovery. Current Drug Discovery Technologies, 7, 22–31.
8.
ChenS.L., SunY.Z., XuJ., LuoH.M., SunC., HeL., ChengX.L., ZhangB.L., XiaoP.G. (2010) Strategies of the study on herb genome program. Yao Xue Xue Bao, 45, 807–812.
9.
LiH.Y., GuoZ., PeterY., QunS., GuJ.K., ZhangJ.W. (2010) Research of traditional Chinese medicine in terms of herbalomics. World Science and Technology, 12, 160–164.
10.
AdomasA., HellerG., OlsonA., OsborneJ., KarlssonM., NahalkovaJ., Van ZylL., SederoffR., StenlidJ., FinlayR., AsiegbuF.Q. (2008) Comparative analysis of transcript abundance in Pinus sylvestris after challenge with a saprotrophic, pathogenic or mutualistic fungus. Tree Physiology, 28, 885–897.
11.
ChengH.M., LiC.C., ChenC.Y., LoH.Y., ChengW.Y., LeeC.H., YangS.Z., WuS.L., HsiangC.Y., HoT.Y. (2010) Application of bioactivity database of Chinese herbal medicine on the therapeutic prediction, drug development, and safety evaluation. Journal of Ethnopharmacology, 132, 429–437.
12.
WenZ., WangZ., WangS., RavulaR., YangL., XuJ., WangC., ZuoZ., ChowM.S., ShiL., HuangY. (2011) Discovery of molecular mechanisms of traditional Chinese medicinal formula Si-Wu-Tang using gene expression microarray and connectivity map. PLoS One, 6, e18278.
13.
LinW.C., TanT.W. (1994) The role of gastric muscle relaxation in cytoprotection induced by San-Huang-Xie-Xin-Tang in rats. Journal of Ethnopharmacology, 44, 171–179.
14.
ChengW.Y., WuS.L., HsiangC.Y., LiC.C., LaiT.Y., LoH.Y., ShenW.S., LeeC.H., ChenJ.C., WuH.C., HoT.Y. (2008) Relationship between San-Huang-Xie-Xin-Tang and its herbal components on the gene expression profiles in HepG2 cells. The American Journal of Chinese Medicine, 36, 783–797.
15.
LambJ. (2007) The Connectivity Map: a new tool for biomedical research. Nature Reviews Cancer, 7, 54–60.
16.
LiS.S. (2007) Commentary–the proteomics: a new tool for Chinese medicine research. The American Journal of Chinese Medicine, 35, 923–928.
17.
ZhangS.X., SunH., SunW.J., JiaoG.Z., WangX.J. (2010) Proteomic study of serum proteins in a type 2 diabetes mellitus rat model by Chinese traditional medicine Tianqi Jiangtang Capsule administration. Journal of Pharmaceutical and Biomedical Analysis, 53, 1011–1014.
18.
Committee of the Pharmacopoeia of PR China. (2005) Pharmacopoeia of PR China. Part 1.Chemical Industry Press, Beijing, China.
19.
XieW.G., MaX.C., ShaoN.S., DingQ.X., ZhaoX., LiuN.L., WeiY.S., WangH.X., ChenK.Y. (2005) Preliminary study on change of serum proteome in noxious heat blood stasis syndrome treated by Radix Paeoniae Rubra. Chinese Journal of Intergrated Traditional and Western Medicine, 6, 520–524.
20.
ChoW.C. (2007) Application of proteomics in Chinese medicine research. The American Journal of Chinese Medicine, 35, 911–922.
21.
FendtS.M., BuescherJ.M., RudroffF., PicottiP., ZamboniN., SauerU. (2010) Tradeoff between enzyme and metabolite efficiency maintains metabolic homeostasis upon perturbations in enzyme capacity. Molecular Systems Biology, 6, 356.
22.
NicholsonJ.K., LindonJ.C., HolmesE. (1999) ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29, 1181–1189.
23.
ZhangA., SunH., WangZ., SunW., WangP., WangX. (2010) Metabolomics: towards understanding traditional Chinese medicine. Planta Medica, 76, 2026–2035.
24.
WangX., LvH., SunH., LiuL., YangB., SunW., WangP., ZhouD., ZhaoL., DouS., ZhangG., CaoH. (2008) Metabolic urinary profiling of alcohol hepatotoxicity and intervention effects of Yin Chen Hao Tang in rats using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 48, 1161–1168.
25.
DeaciucI.V., Nikolova-KarakashianM., FortunatoF., LeeE.Y., HillD.B., McClainC.J. (2000) Apoptosis and dysregulated ceramide metabolism in a murine model of alcohol-enhanced lipopolysaccharide hepatotoxicity. Alcoholism, Clinical and Experimental Research, 24, 1557–1565.
26.
JonesB.E., LoC.R., SrinivasanA., ValentinoK.L., CzajaM.J. (1999) Ceramide induces caspase-independent apoptosis in rat hepatocytes sensitized by inhibition of RNA synthesis. Hepatology, 30, 215–222.
27.
BateyR.G., WangJ. (2002) Molecular pathogenesis of T lymphocyte-induced liver injury in alcoholic hepatitis. Frontiers in Bioscience, 7, d1662–1675.
28.
De VitoW.J., XhajaK., StoneS. (2000) Prenatal alcohol exposure increases TNFalpha-induced cytotoxicity in primary astrocytes. Alcohol, 21, 63–71.
29.
TanG., LiaoW., DongX., YangG., ZhuZ., LiW., LouZ. (2012) Metabonomic profiles delineate the effect of traditional Chinese medicine sini decoction on myocardial infarction in rats. PLoS One, 7, e34157.
30.
WuW., SuJ., LinS. (1999) Clinical study on therapeutic mechanism of Sini decoction in treating post-percutaneous transluminal coronary angioplasty ischemia-reperfusion injury in terms of syndrome typing of TCM. Chinese Journal of Intergrated Traditional and Western Medicine, 19, 23–26.
31.
WangJ.F., ZhouH., HanL.Y., ChenX., ChenY.Z., CaoZ.W. (2005) Traditional Chinese medicine information database. Clinical Pharmacology and Therapeutics, 78, 92–93.
32.
ChenC.Y. (2011) TCM Database@Taiwan: The world's largest traditional Chinese medicine database for drug screening in silico. PLoS One, 6, e15939.
XueR., FangZ., ZhangM., YiZ., WenC., ShiT. (2013) TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Research, 41, D1089–D1095.
35.
ChengT.O. (2006) Danshen: a versatile Chinese herbal drug for the treatment of coronary heart disease. International Journal of Cardiology, 113, 437–438.
36.
TianL.L., WangX.J., SunY.N., LiC.R., XingY.L., ZhaoH.B., DuanM., ZhouZ., WangS.Q. (2008) Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells. The International Journal of Biochemistry & Cell Biology, 40, 409–422.
37.
WongC.K., BaoY.X., WongE.L., LeungP.C., FungK.P., LamC.W. (2005) Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. The American Journal of Chinese Medicine, 33, 381–395.
38.
BrimkmanR.R., DubéM.P., RouleauG.A., OrrA.C., SamuelaM.E. (2006) Human monogenic disorders - a source of novel drug targets. Nature Reviews Genetics, 7, 249–260.
39.
WangZ.Y., ZhangH.Y. (2013) Rational drug repositioning by medical genetics. Nature Biotechnology, 31, 1080–1082.
40.
Huang daW., ShermanB.T., LempickiR.A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols, 4, 44–57.
ShiZ., HeJ., YaoT., ChangW., ZhaoM. (2005) Simultaneous determination of cryptotanshinone, tanshinone I and tanshinone IIA in traditional Chinese medicinal preparations containing Radix salvia miltiorrhiza by HPLC. Journal of Pharmaceutical and Biomedical Analysis, 37, 481–486.
43.
LiuL., ZhangH.Q. (2003) Advances in contemporary traditional Chinese medicine (TCM) pharmacology studies of active constituents of Danshen (Salvia miltiorrhiza). Chinese Wild Plant Resources, 22, 1–4.
